Immunomodulatory functions of low-molecular weight hyaluronate in an acute rat renal allograft rejection model

Journal of the American Society of Nephrology

Volumn 10, Issue 5, 1999, Pages 1059-1066

  Knoflach, Andreas ^a   Azuma, Haruhito ^a   Magee, Colm ^a   Denton, Mark ^a   Murphy, Barbara ^a   Iyengar, Anand ^a   Buelow, Roland ^a,b   Sayegh, Mohamed H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A; GAMMA INTERFERON; HYALURONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION; IMMUNOMODULATION; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; MIXED LYMPHOCYTE REACTION; NEPHRECTOMY; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032930323     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Fuggle SV, Koo DD: Cell adhesion molecules in clinical renal transplantation. Transplantation 65: 763-769, 1998
2. DeGrendele HC, Estess P, Siegelman MH: Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 278: 672-675, 1997
3. Mohamadzadeh M, DeGrendele H, Arizpe H, Estess P, Siegelman M: Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. J Clin Invest 101: 97-108, 1998
4. Naot D, Sionov RV, Ish-Shalom D: CD44: Structure, function, and association with the malignant process. Adv Cancer Res 71: 241-319, 1997
5. Borland G, Ross JA, Guy K: Forms and functions of CD44. Immunology 93: 139-148, 1998
6. Guo Y, Wu Y, Shinde S, Sy MS, Aruffo A, Liu Y: Identification of a costimulatory molecule rapidly induced by CD40L as CD44H. J Exp Med 184: 955-961, 1996
7. Toole BP: Hyaluronan in morphogenesis. J Intern Med 242: 35-40, 1997
8. Gerdin B, Hallgren R: Dynamic role of hyaluronan (HYA) in connective tissue activation and inflammation. J Intern Med 242: 49-55, 1997
9. Hallgren R, Gerdin B, Tufveson G: Hyaluronic acid accumulation and redistribution in rejecting rat kidney graft: Relationship to the transplantation edema. J Exp Med 171: 2063-2076, 1990
10. Wells A, Larsson E, Hanas E, Laurent T, Hallgren R, Tufveson G: Increased hyaluronan in acutely rejecting human kidney grafts. Transplantation 55: 1346-1349, 1993
11. Rao PN, Zeevi A, Snyder J, Spichty K, Habrat T, Warty V, Dauber J, Paradis I, Duncan S, Pham S: Monitoring of acute lung rejection and infection by bronchoalveolar lavage and plasma levels of hyaluronic acid in clinical lung transplantation. J Heart Lung Transplant 13: 958-962, 1994
12. Laurent TC, Laurent UB, Fraser JR: Serum hyaluronan as a disease marker. Ann Med 28: 241-253, 1996
13. Turley EA: Hyaluronan and cell locomotion. Cancer Metastasis Rev 11: 21-30, 1992
14. Savani RC, Wang C, Yang B, Zhang S, Kinsella MG, Wight TN, Stern R, Nance DM, Turley EA: Migration of bovine aortic smooth muscle cells after wounding injury: The role of hyaluronan and RHAMM. J Clin Invest 95: 1158-1168, 1995
15. McCourt PA, Ek B, Forsberg N, Gustafson S: Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan. J Biol Chem 269: 30081-30084, 1994
16. Hofmann M, Fieber C, Assmann V, Gottlicher M, Sleeman J, Plug R, Howells N, von Stein O, Ponta H, Herrlich P: Identification of IHABP, a 95 kDa intracellular hyaluronate binding protein. J Cell Sci 111: 1673-1684, 1998
17. Denton MD, Magee CC, Sayegh MH: Immunosuppressive strategies in transplantation. Lancet 1999, in press
18. Paul LC, Davidoff A, Benediktsson H, Issekutz T: Anti-integrin (LFA-1, VLA-4, and Mac-1) antibody treatment and acute cardiac graft rejection in the rat. Transplant Int 9: 420-425, 1996
19. Nemec RE, Toole BP, Knudson W: The cell surface hyaluronate binding sites of invasive human bladder carcinoma cells. Biochem Biophys Res Commun 149: 249-257, 1987
20. Zeng C, Toole BP, Kinney SD, Kuo JW, Stamenkovic I: Inhibition of tumor growth in vivo by hyaluronan oligomers. Int J Cancer 77: 396-401, 1998
21. Sayegh MH, Akalin E, Hancock WW, Russell ME, Carpenter CB, Linsley PS, Turka LA: CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 181: 1869-1874, 1995
22. Solez K, Axelsen RA, Benediktsson H, Burdick JE, Cohen AH, Colvin RB, Croker BP, Droz D, Dunnill MS, Halloran PF: International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 44: 411-422, 1993
23. Estess P, DeGrendele HC, Pascual V, Siegelman MH: Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity. J Clin Invest 102: 1173-1182, 1998
24. Seiter S, Weber B, Tilgen W, Zoller M: Down-modulation of host reactivity by anti-CD44 in skin transplantation. Transplantation 66: 778-791, 1998
25. Denning SM, Le PT, Singer KH, Haynes BF: Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J Immunol 144: 7-15, 1990
26. Guo YJ, Ma J, Wong JH, Lin SC, Chang HC, Bigby M, Sy MS: Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas. Cell Immunol 152: 186-199, 1993
27. Rafi-Janajreh AQ, Nagarkatti PS, Nagarkatti M: Role of CD44 in CTL and NK cell activity. Front Biosci 3: D665-D671, 1998
28. Johnsson C, Tufveson G, Wahlberg J, Hallgren R: Experimentally induced warm renal ischemia induces cortical accumulation of hyaluronan in the kidney. Kidney Int 50: 1224-1229, 1996